841.31
前日終値:
$796.35
開ける:
$808.3
24時間の取引高:
1.29M
Relative Volume:
1.18
時価総額:
$98.50B
収益:
$403.43B
当期純損益:
$5.10B
株価収益率:
21.87
EPS:
38.4657
ネットキャッシュフロー:
$5.41B
1週間 パフォーマンス:
+6.12%
1か月 パフォーマンス:
+7.11%
6か月 パフォーマンス:
+0.10%
1年 パフォーマンス:
+17.54%
Mckesson Corp Stock (MCK) Company Profile
Compare MCK vs COR, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
MCK
Mckesson Corp
|
841.31 | 98.50B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
307.99 | 59.92B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
228.72 | 53.57B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
88.26 | 10.05B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
1.56 | 1.34B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2024-12-04 | 再開されました | Mizuho | Neutral |
| 2024-11-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | 繰り返されました | Leerink Partners | Outperform |
| 2024-08-08 | 繰り返されました | Mizuho | Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Overweight |
| 2022-07-06 | ダウングレード | Argus | Buy → Hold |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-02-04 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-01-07 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | 繰り返されました | Barclays | Overweight |
| 2021-11-02 | 繰り返されました | BofA Securities | Buy |
| 2021-11-02 | 繰り返されました | Evercore ISI | Outperform |
| 2021-11-02 | 繰り返されました | Jefferies | Buy |
| 2021-03-30 | アップグレード | Argus | Hold → Buy |
| 2020-11-02 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-08-04 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-05-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | アップグレード | UBS | Neutral → Buy |
| 2020-04-23 | 再開されました | Credit Suisse | Neutral |
| 2020-03-18 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-13 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-08-05 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | 開始されました | Guggenheim | Neutral |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2018-10-26 | 繰り返されました | Barclays | Equal Weight |
| 2018-07-20 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2018-03-08 | 開始されました | Barclays | Equal Weight |
| 2018-02-27 | 再開されました | BofA/Merrill | Buy |
| 2018-02-02 | 繰り返されました | Mizuho | Neutral |
| 2018-01-24 | アップグレード | Jefferies | Hold → Buy |
すべてを表示
Mckesson Corp (MCK) 最新ニュース
McKesson's Q1 2027 Earnings: What to Expect - Barchart.com
A Look at McKesson Corp (MCK) After 5.7% Gain -- GF Value $794.81 vs Price $841.31 - GuruFocus
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
LLY5237191 Bond Profile — Key Metrics - TradingView
XS156717452 Bond Profile — Key Metrics - TradingView
LLY6082068 Bond Profile — Key Metrics - TradingView
McKesson (MCK) Stock Dips While Market Gains: Key Facts - Yahoo Finance
McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
McKesson stock holds steady as healthcare distribution scale anchors long-term appeal - Ad-hoc-news.de
A19WCE Bond Profile — Key Metrics - TradingView
MCKC Bond Profile — Key Metrics - TradingView
McKesson Stock (MCK) Opinions on Political Stock Purchases - Quiver Quantitative
McKesson publishes Impact Report with key milestones - HME News
MCK.GL Bond Profile — Key Metrics - TradingView
McKesson (MCK) Falls After CEO Share Sale, Is The 14% Discount Enough? - Yahoo Finance
McKesson stock reflects steady healthcare distribution strength - ad-hoc-news.de
Ritchie John Torres purchases McKesson Corporation stock - Investing.com
McKesson (MCK) Stock Trades Down, Here Is Why - Yahoo Finance
McKesson Corporation's Stock Price Drops to $792.81, Experiencing a 3.16% Decline: An In-depth Analysis - Smartkarma
Is McKesson Corp (MCK) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
McKesson Falls as Investors Weigh Recent Leadership Changes and Prior Revenue Concerns - Quiver Quantitative
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson's Oncology Leadership and Robust Free Cash Flow Underpin Strong Durable Fundamentals - Morningstar
Congressional Trading Report: Rep. Ritchie Torres Bought Over $1K In McKesson Stock - Benzinga
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet - Yahoo Finance
Meet the Dallas 500: Brian Tyler, McKesson Corp. - D Magazine
McKesson CEO Brian Tyler sells $6.7 million in company shares - Investing.com
McKesson CEO Brian Tyler sells $6.7 million in company shares By Investing.com - Investing.com Nigeria
Form 4 McKesson For: 8 July By Investing.com - Investing.com Canada
McKesson (MCK) CEO’s 8,463-share sale executed under Rule 10b5-1 plan - Stock Titan
McKesson Checks All The Boxes To Survive And Prosper In A Weak Economy, But There's A Big Catch - Seeking Alpha
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
McKesson wound care portfoliodiscreet dressings for home patients - ad-hoc-news.de
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Form 144 MCKESSON CORP For: 7 July By Investing.com - Investing.com Nigeria
McK (NYSE: MCK) Form 144 shows Brian S. Tyler plans to sell shares - Stock Titan
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? - The Motley Fool
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
McKesson posts Q1 earnings beat, but revenue misses estimates; Shares fall 2% - Investing.com
McKesson: The Healthcare Supplier On My Buy List This Summer, As Growth Accelerates (NYSE:MCK) - Seeking Alpha
MCKMckesson Corp Latest SEC Filings - Finviz
McKesson Stock (MCK) Opinions on Market Focus and Dividend Growth - Quiver Quantitative
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - Yahoo Finance
McKesson (MCK) Spotlights AI-Powered Tools for Independent Pharmacies at Its Annual ideaShare Conference - Insider Monkey
McKesson exec to retire in another C-suite change for pharma giant - The Business Journals
McKesson Corporation (MCK) Announces Executive Leadership Transi - GuruFocus
McKesson (NYSE: MCK) EVP Rodgers to retire, Srinivasan to lead strategy - Stock Titan
List of 30 Acquisitions by McKesson (Jul 2026) - Tracxn
McKesson Patient Room Hygiene Kit from McKessonSmall accessory, big impact on hospital safety - AD HOC NEWS
The McKesson Brand Insulin SyringeSmall detail that shapes diabetes care - AD HOC NEWS
Will Defensive Index Additions and TempraMed Deal Change McKesson's (MCK) Risk Perception Narrative - Yahoo Finance
Mckesson Corp (MCK) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):